scholarly journals Premature atherosclerosis and acute coronary syndrome in a child with end-stage renal disease

2021 ◽  
Vol 69 (1) ◽  
Author(s):  
Tülay Becerir ◽  
Münevver Yılmaz ◽  
İlknur Girişgen ◽  
Neslihan Yılmaz ◽  
Dolunay Gürses ◽  
...  
Keyword(s):  
Acute Coronary Syndrome ◽  
Renal Disease ◽  
End Stage Renal Disease ◽  
Left Coronary Artery ◽  
Premature Atherosclerosis ◽  
Case Presentation ◽  
Coronary Syndrome ◽  
Life Saving ◽  
Stage Renal Disease ◽  
End Stage

Abstract Background Although acute coronary syndrome is rare in children, it is the most important cause of mortality in children with end-stage renal disease. Case presentation Here, a 16-year-old pediatric patient, who has been on dialysis since the age of 3, and who was diagnosed with acute coronary syndrome and placed an emergency percutaneous transcatheter stent in the left anterior descending branch of the left coronary artery is presented. It is important that the present patient does not have any electrocardiography findings in favor of cardiovascular disease and that he cannot fully explain the complaint of chest pain due to his mental retardation. Conclusions Early detection of acute coronary syndrome is life-saving, especially in children with chronic kidney disease.

scholarly journals Risk of acute coronary syndrome after parathyroidectomy in patients with end-stage renal disease: A population-based cohort study in Taiwan

Nephrology ◽  
2018 ◽  
Vol 23 (2) ◽  
pp. 139-147 ◽  
Author(s):  
Tsung Liang Ma ◽  
Rei Yeuh Chang ◽  
Hsuan Ju Chen ◽  
Chun Yi Liu ◽  
Chih Cheng Hsu ◽  
...  
Keyword(s):  
Acute Coronary Syndrome ◽  
Cohort Study ◽  
Renal Disease ◽  
End Stage Renal Disease ◽  
Population Based ◽  
Coronary Syndrome ◽  
Stage Renal Disease ◽  
End Stage

scholarly journals Apolipoprotein c-iii (apo-c3) Metabolism in Patients with End Stage Renal Disease Treated with Long Term Hemodialysis

2018 ◽  
Vol 2 (2) ◽  
pp. 174-181
Author(s):  
Lutfi Zylbeari ◽  
Kastriot Haxhirexha ◽  
Nasir Behxheti ◽  
Ferizate Dika- Haxhirexha ◽  
Gazmend Zylbeari ◽  
...  
Keyword(s):  
Renal Disease ◽  
Kidney Failure ◽  
End Stage Renal Disease ◽  
Public Health Problem ◽  
Chronic Kidney Failure ◽  
The United States ◽  
Coronary Syndrome ◽  
Poor Outcomes ◽  
Stage Renal Disease ◽  
End Stage

Background: End Stage Renal disease (ESRD) as it was historically termed is a term that encompasses all degrees of decreased renal function, from damaged–at risk through mild, moderate, and severe chronic kidney failure. ESRD is a worldwide public health problem. In the United States, there is a rising incidence and prevalence of kidney failure, with poor outcomes and high cost (see Epidemiology).Material and Methods: The blood sample for routine analysis (lipidogram) and specific analysis was taken at 08o'clock in the morning with the room temperature that variated from 19 to 24°C, before the hemodialysis session, minimum 12 hours of fasting - with tendency to avoid the absorption effect of food by the intestine as well as avoid absorption of lipids and formation of chilomicrones. In all samples regardless of their group, the concentration of ApoC-II and lipids were analyzed in a period of 12 months in a period of 12 months (the measurements were made every three months, it means we totally made 3 measurements in 9 months).Results: The results from patients and controlling group for Apo-C3 and lipid profile (ChT, TG, HDL-ch, LDL-ch) are given in table number 3. A significant statistical difference with p<0.0001 is found from the results of the lipidic profile and ApoC-III of patients with ESRD treated with HD compared with the results of the controlling group for the same parameters.Conclusion: In this study patients with ESRD treated with HD have high parameters of ApoC-III, TG, LDL-ch but low concentrations of HDL-ch due to impaired catabolism of apolipoproteins in this specific group of patients. In all patients symptoms of CDV (myocardial infarction, angina pectoris, ischemia), acute coronary syndrome were noticed.

scholarly journals Excision of brain tumour in a peritoneal dialysis dependent patient by awake craniotomy: a case report

2021 ◽  
Vol 13 (1) ◽  
Author(s):  
Debashree Roy ◽  
Subhajit Guha ◽  
Dimple Shah ◽  
Indranil Ghosh
Keyword(s):  
Peritoneal Dialysis ◽  
Renal Disease ◽  
End Stage Renal Disease ◽  
Awake Craniotomy ◽  
Safe Alternative ◽  
Case Presentation ◽  
High Prevalence ◽  
Risk Patients ◽  
Stage Renal Disease ◽  
End Stage

Abstract Background End-stage renal disease has a high prevalence worldwide. Quiet often, we come across patients with end-stage renal disease surviving on haemodialysis or peritoneal dialysis who need surgery. The management of such patients is a challenging task for the anaesthesiologist. Case presentation A patient suffering from end-stage renal disease on peritoneal dialysis was posted for removal of supratentorial space occupying lesion in our operation theatre. We describe the successful management of this case by the technique of awake craniotomy. Conclusion Awake craniotomy can be a safe alternative for high-risk patients undergoing craniotomy for brain tumours.

scholarly journals Apolipoprotein c-iii (apo-c3) Metabolism in Patients with End Stage Renal Disease Treated with Long Term Hemodialysis.

2018 ◽  
Vol 2 (2) ◽  
Author(s):  
Lutfi Zylbeari ◽  
Kastriot Haxhirexha ◽  
Nasir Behxheti ◽  
Ferizate Dika Haxhirexha ◽  
Gazmend Zylbeari ◽  
...  
Keyword(s):  
Renal Disease ◽  
Kidney Failure ◽  
End Stage Renal Disease ◽  
Public Health Problem ◽  
Chronic Kidney Failure ◽  
The United States ◽  
Coronary Syndrome ◽  
Poor Outcomes ◽  
Stage Renal Disease ◽  
End Stage

Background: End Stage Renal disease (ESRD) as it was historically termed is a term that encompasses all degrees of decreased renal function, from damaged–at risk through mild, moderate, and severe chronic kidney failure. ESRD is a worldwide public health problem. In the United States, there is a rising incidence and prevalence of kidney failure, with poor outcomes and high cost (see Epidemiology).Material and Methods: The blood sample for routine analysis (lipidogram) and specific analysis was taken at 08o'clock in the morning with the room temperature that variated from 19 to 24°C, before the hemodialysis session, minimum 12 hours of fasting - with tendency to avoid the absorption effect of food by the intestine as well as avoid absorption of lipids and formation of chilomicrones. In all samples regardless of their group, the concentration of ApoC-II and lipids were analyzed in a period of 12 months in a period of 12 months (the measurements were made every three months, it means we totally made 3 measurements in 9 months).Results: The results from patients and controlling group for Apo-C3 and lipid profile (ChT, TG, HDL-ch, LDL-ch) are given in table number 3. A significant statistical difference with p<0.0001 is found from the results of the lipidic profile and ApoC-III of patients with ESRD treated with HD compared with the results of the controlling group for the same parameters.Conclusion: In this study patients with ESRD treated with HD have high parameters of ApoC-III, TG, LDL-ch but low concentrations of HDL-ch due to impaired catabolism of apolipoproteins in this specific group of patients. In all patients symptoms of CDV (myocardial infarction, angina pectoris, ischemia), acute coronary syndrome were noticed.

Sign in / Sign up

Export Citation Format

Share Document